Hexagon Capital Partners’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-956
| Closed | -$48.7K | – | 1304 |
|
|
2025
Q1 | $48.7K | Sell |
956
-81
| -8% | -$4.13K | 0.01% | 475 |
|
|
2024
Q4 | $46.8K | Sell |
1,037
-8
| -0.8% | -$361 | 0.01% | 503 |
|
|
2024
Q3 | $38.8K | Sell |
1,045
-213
| -17% | -$7.9K | 0.01% | 503 |
|
|
2024
Q2 | $38.5K | Buy |
1,258
+190
| +18% | +$5.81K | 0.01% | 492 |
|
|
2024
Q1 | $31.1K | Buy |
1,068
+89
| +9% | +$2.59K | 0.01% | 542 |
|
|
2023
Q4 | $27K | Buy |
979
+557
| +132% | +$15.4K | 0.01% | 556 |
|
|
2023
Q3 | $9.46K | Buy |
422
+253
| +150% | +$5.67K | ﹤0.01% | 767 |
|
|
2023
Q2 | $6.87K | Sell |
169
-2
| -1% | -$81 | ﹤0.01% | 835 |
|
|
2023
Q1 | $8.28K | Sell |
171
-27
| -14% | -$1.31K | ﹤0.01% | 775 |
|
|
2022
Q4 | $7.56K | Sell |
198
-52
| -21% | -$1.99K | ﹤0.01% | 803 |
|
|
2022
Q3 | $13K | Buy |
250
+151
| +153% | +$7.85K | ﹤0.01% | 703 |
|
|
2022
Q2 | $4K | Buy |
+99
| New | +$4K | ﹤0.01% | 853 |
|